2024-11-28 08:33:30
Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML
Corporate/ 2023-07-24
Kronos Bio and Invivoscribe Partner on C...

Companion diagnostic would be used following potential regulatory approval of entospletinib to screen for NPM1 mutation present in approxima...

Global Cord Blood Corporation Files Annual Report on Form 20-F
Corporate/ 2023-07-24
Global Cord Blood Corporation Files Annu...

HONG KONG,Aug. 17,2022-- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China\'s leading provider of...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release